Search Results1-1 of  1

  • FOR THE JAPAN ADULT LEUKEMIA STUDY GROUP (JALSG) ID: 9000000451680

    Articles in CiNii:1

    • No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study (1999)
Page Top